The challenge. There is no single regulatory route — there is the right route for your product, in your market. Choosing the wrong pathway, classification or timing costs months and budget; a regulatory plan disconnected from the commercial plan costs even more.
View area in detail →The challenge. A good product is not enough — you need to know who to license it to, who to distribute it with, and whether the opportunity justifies the investment. Many companies enter negotiations without a solid commercial assessment, or leave portfolio value untapped for lack of knowing where it is worth most.
View area in detail →The challenge. Authorisation is not the end of the road — it is the beginning. Without a pricing, reimbursement and route-to-market strategy, an approved product may never reach the patient. Hospital, tender and reimbursement environments in Portugal and Spain have their own rules — and those rules decide commercial success.
View area in detail →The challenge. Expanding is not picking a country on a map — it is choosing the market where your product has a real probability of success, with the documentation ready and the right partner on the other side. For international companies, Portugal and Spain are gateways into Europe with their own rules and dynamics; for Iberian companies, the challenge is choosing where to grow next.
View area in detail →The challenge. Strategy is decided in meetings; the product moves through warehouses, transport and quality systems. Between authorisation and the first sale there is a distribution model to set up, GDP requirements to meet and a local operation to prepare — and this is where many launches slip.
View area in detail →The challenge. There are moments when a company needs senior experience — a difficult decision, a delayed project, a vacant role — but cannot justify, or cannot achieve, permanent recruitment. This service exists for those moments.
View area in detail →Describe the project — we will identify the relevant issues.
